CTOs on the Move

Genomics Institute of the Novartis Research Foun

www.gnf.org

 
Genomics Institute of the Novartis Research Foundation (GNF) is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.gnf.org
  • 10675 John J Hopkins Dr
    San Diego, CA USA 92121
  • Phone: 858.812.1500

Executives

Name Title Contact Details

Similar Companies

Prestige Health Choice

Prestige Health Choice is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthSmart

For more than 40 years, HealthSmart has offered a wide array of customizable and scalable health plan solutions for self-funded employers. HealthSmart`s comprehensive service suite addresses individual health from all angles. This includes claims and benefits administration, provider networks, pharmacy benefit management services, business intelligence, onsite employer clinics, care management, a variety of health and wellness initiatives and web-based reporting. The Company`s headquarters is in Irving, Texas, with regional hubs throughout the country. HealthSmart`s mission is to improve member health and reduce healthcare costs.

Copies - FYI

Copies - FYI is a Lenexa, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Person Memorial Hospital

Person Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Person Memorial Hospital is based in Roxboro, NC. You can find more information on Person Memorial Hospital at www.personhospital.com

iRhythm

iRhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. Our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ECG, monitoring for patients at risk for arrhythmias. We have created a unique platform, ZIO by iRhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.